Wilkoff, BL, Fauchier, L, Stiles, MK, Morillo, CA, Al-Khatib, SM, Almendral, J, Aguinaga, L, Berger, RD, Cuesta, A, Daubert, JP, Dubner, S, Ellenbogen, KA, Estes, NAM, Fenelon, G, Garcia, FC, Gasparini, M, Haines, DE, Healey, JS, Hurtwitz, JL, Keegan, R, Kolb, C, Kuck, KH, Marinskis, G, Martinelli, M, McGuire, M, Molina, LG, Okumura, K, Proclemer, A, Russo, AM, Singh, JP, Swerdlow, CD, Teo, WS, Uribe, W, Viskin, S, Wang, CC, Zhang, S, Boriani, G, Brignole, M, Cheng, A, Crawford, TC, Di Biase, L, Donahue, K, Epstein, AE, Field, ME, Gorenek, B, Huang, JL
, Indik, JH, Israel, CW, Jessup, ML, Leclercq, C, Macfadyen, RJ, Madias, C, Marquez, MF, Olshansky, B, Patton, KK, Refaat, MM, Tracy, CM, Upadhyay, GA, Vanegas, D & Wang, PJ 2016, '
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing',
Europace, vol. 18, no. 2, pp. 159-183.
https://doi.org/10.1093/europace/euv411